Exponent (EXPO) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Exponent

NasdaqGS•Industrials•Engineering & Construction

$68.01+0.67(0.01%)Pre-market

Market Cap

$3.33B

P/E

29.8x

P/S

5.3x

P/B

11.5x

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

How this company scores

GoodMetricSide Score: 74/100

Strongest: Profitability (21/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability21/25

Growth21/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality17/25

Strengths

Strong marginsHigh ROEInterest easily coveredCash-backed earnings

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 29.8x5y range 29.8x – 60.3x

Currently below its 20-quarter median.

P/S · 5.3x5y range 5.3x – 17.5x

Currently below its 20-quarter median.

P/B · 11.5x5y range 8.6x – 16.0x

Price & Volume

Market Cap $3.33B

Metrics at a Glance

as of July 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $632.46M
Q. Revenue: $171.61M
TTM EBITDA: $137.84M
TTM Op. Income: $127.58M
Q. Op. Income: $28.02M
TTM Net Income: $111.77M
Q. Net Income: $29.39M
EPS: $0.6
Shares Out.: $48.75M

$632.46M in TTM revenue grew 12.8% YoY, reaching $171.61M last quarter. TTM EBITDA of $137.84M and TTM operating income of $127.58M show growth is flowing through to the bottom line. TTM net income of $111.77M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 17.9%
Op. Margin: 16.3%
Net Margin: 17.1%

Op. margin of 16.3% is up 4.2% YoY — cost efficiency is improving. Net margin at 17.1% Over the past year, operating margin is up 35% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 29.8x
P/S Ratio: 5.3x
P/B Ratio: 11.5x

At 29.8x P/E, the stock trades within typical market levels. P/S of 5.3x and P/B of 11.5x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $652.72M
Cash: $66.63M
Long-Term Debt: N/A
Book Value: $288.62M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $30.89M
TTM Free Cash Flow: $108.56M
FCF Margin: 17.2%
FCF / Net Income: 1.0

TTM FCF of $108.56M on $30.89M in operating cash flow. The FCF / Net Income ratio of 1.0x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 3 consecutive quarters — a weakening trend.